MIR96: A Potential Drug Target and Biomarker (G407053)

Target Name: MIR96

NCBI ID: G407053

MIR96

MIR96: A Potential Drug Target and Biomarker

MIR96, also known as hsa-mir-96, is a protein that is expressed in various tissues of the human body, including the liver, pancreas, and muscle. It is a member of the mir gene family, which encodes for small non- coding RNAs (ncRNAs) that play a critical role in post-transcriptional gene regulation. mir96 is one of the most well-studied members of the mir gene family, and several studies have identified its potential as a drug target or biomarker.

The mir gene family is characterized by the presence of a conserved core sequence that is located upstream of the protein coding region. This core sequence is responsible for the formation of a stem-loop structure, which is a common feature of small non-coding RNAs . The stem-loop region is also home to several conserved secondary structure elements, including a poly(A) tail, which is important for the stability and translation of these RNAs.

MIR96 is a 96 amino acid long protein that is expressed in the liver, pancreas, and muscle. It is highly conserved, with only one known splice variant. MIR96 is predominantly expressed in the liver, with lower levels detected in the pancreas and muscle. It is also highly expressed in the liver cell surface, where it is involved in the regulation of cellular processes such as cell adhesion, migration, and signaling.

Several studies have identified potential drug targets in MIR96. One of the most promising targets is the PI3K/AKT signaling pathway, which is a critical pathway involved in the regulation of cellular signaling pathways. MIR96 has been shown to be involved in the regulation of this pathway, and several studies have identified potential binding sites for small molecules that can inhibit its activity. Additionally, MIR96 has been shown to be involved in the regulation of cellular processes that are important for cancer progression, such as cell survival, angiogenesis, and metastasis.

MIR96 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Several studies have shown that MIR96 is overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, MIR96 has has been shown to be involved in the regulation of cellular processes that are important for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In conclusion, MIR96 is a protein that has been well-studied for its potential as a drug target and biomarker. Its conserved core sequence and multiple functions make it an attractive target for small molecules, and its potential as a drug target or biomarker has significant implications for the development of new treatments for a variety of diseases. Further research is needed to fully understand the functions of MIR96 and its potential as a drug target and biomarker.

Protein Name: MicroRNA 96

The "MIR96 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR96 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets